Company: BWAY
Filing Date: 2025-05-01
Form Type: 424B3
Source: 0001171843-25-002668
Chunk: 0

Company: Brainsway Ltd.
Filing Date: 2025-05-01
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-286672

PROSPECTUS

<div align='center'>Up to 3,603,745 American Depositary Shares representing 7,207,490 Ordinary Shares

BRAINSWAY LTD.</div>

This prospectus relates to the offer and sale from
time to time by the selling shareholder named in this prospectus of up to an aggregate of 3,603,745 of our American Depositary Shares
(the “Offered ADSs”), with each American Depositary Share (“ADS”) representing two of our ordinary shares, NIS
0.04 par value per share (the “Ordinary Shares”), or 7,207,490 Ordinary Shares in the aggregate. The Offered ADSs consist
of (i) 2,103,745 ADSs, representing 4,207,490 Ordinary Shares, that were issued pursuant to a securities purchase agreement (the
“Purchase Agreement”), dated as of September 29, 2024, between us and the selling shareholder and (ii) 1,500,000 ADSs,
representing 3,000,000 Ordinary Shares, issuable upon the exercise of a warrant (the “Warrant”) that was issued in connection
with the Purchase Agreement.

We are required to register these securities for resale
pursuant to a registration rights agreement entered into between us and the selling shareholder on September 29, 2024, as amended on November
5, 2024 (the “Registration Rights Agreement”). Our registration of the securities covered by this prospectus does not mean
that the selling shareholder will offer or sell any of the securities registered hereby.

We will not receive proceeds from any sales of the
Offered ADSs by the selling shareholder. However, we will receive the exercise price upon any exercise of the Warrant, to the extent exercised
on a cash basis. Any ADSs subject to resale hereunder will have been issued by us and acquired by the selling shareholder prior to any
resale of such shares pursuant to this prospectus.

The selling shareholder named in this prospectus and
any of its pledgees, assignees and successors-in-interest, may offer or resell the Offered ADSs from time to time through public or private
transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The selling
shareholder will bear all commissions and discounts, if any, attributable to the sale of the Offer